*By Carlo Versano*
President Trump's former campaign chair Paul Manafort is, as of Friday, the latest of the president's ex-associates to plead guilty to felony charges.
Manafort was convicted in federal court in August of eight financial fraud charges, though "this is the first time time Paul Manafort has ever admitted to committing a crime," Ben Dreyfuss, editorial director of Mother Jones, said.
Friday's plea deal was related to a separate set of charges for which the former political consultant was awaiting trial.
As part of the plea, Manafort will cooperate with Special Counsel Robert Mueller's investigation into Russian interference in the 2016 presidential election.
That is "massive news," Dreyfuss said.
Trump praised Manafort as a "brave man" when he was found guilty of bank and tax fraud last month ー roughly the same hour when Trump's former consigliere Michael Cohen was offering to cooperate, much to the chagrin of the president.
Manafort's lawyer said Friday his client had offered "full cooperation," though as Dreyfuss noted, no details have been made public yetー and what specifically Manafort could offer prosecutors remains unknown.
"No one knows what he could say except for Trump himself," Dreyfuss said.
A new poll finds most U.S. adults are worried about health care becoming more expensive.
The White House budget office says mass firings of federal workers have started in an attempt to exert more pressure on Democratic lawmakers as the government shutdown continues.
President Donald Trump says “there seems to be no reason” to meet with Chinese leader Xi Jinping as part of an upcoming trip to South Korea after China restricted exports of rare earths needed for American industry. The Republican president suggested Friday he was looking at a “massive increase” of import taxes on Chinese products in response to Xi’s moves. Trump says one of the policies the U.S. is calculating is "a massive increase of Tariffs on Chinese products coming into the United States." A monthslong calm on Wall Street was shattered, with U.S. stocks falling on the news. The Chinese Embassy in Washington hasn't responded to an Associated Press request for comment.
Most members of the Federal Reserve’s interest-rate setting committee supported further reductions to its key interest rate this year, minutes from last month’s meeting showed.
From Wall Street trading floors to the Federal Reserve to economists sipping coffee in their home offices, the first Friday morning of the month typically brings a quiet hush around 8:30 a.m. eastern, as everyone awaits the Labor Department’s monthly jobs report.
The Supreme Court is allowing Lisa Cook to remain as a Federal Reserve governor for now.
Rep. John Moolenaar has requested an urgent briefing from the White House after Trump supported a deal giving Americans a majority stake in TikTok.
A new report finds the Department of Government Efficiency’s remaking of the federal workforce has battered the Washington job market and put more households in the metropolitan area in financial distress.
A new poll finds U.S. adults are more likely than they were a year ago to think immigrants in the country legally benefit the economy. That comes as President Donald Trump's administration imposes new restrictions targeting legal pathways into the country. The Associated Press-NORC Center for Public Affairs Research survey finds Americans are more likely than they were in March 2024 to say it’s a “major benefit” that people who come to the U.S. legally contribute to the economy and help American companies get the expertise of skilled workers. At the same time, perceptions of illegal immigration haven’t shifted meaningfully. Americans still see fewer benefits from people who come to the U.S. illegally.
Shares of Tylenol maker Kenvue are bouncing back sharply before the opening bell a day after President Donald Trump promoted unproven and in some cases discredited ties between Tylenol, vaccines and autism. Trump told pregnant women not to use the painkiller around a dozen times during the White House news conference Monday. The drugmaker tumbled 7.5%. Shares have regained most of those losses early Tuesday in premarket trading.
